SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-207507
Filing Date
2013-05-08
Accepted
2013-05-08 16:15:09
Documents
3
Period of Report
2013-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d535538d8k.htm 8-K 16557
2 EX-99.1 d535538dex991.htm EX-99.1 92322
3 GRAPHIC g535538g93h14.jpg GRAPHIC 5685
  Complete submission text file 0001193125-13-207507.txt   118190
Mailing Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656
Business Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS, INC. (Filer) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-15803 | Film No.: 13824709
SIC: 2834 Pharmaceutical Preparations